Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Bupleurum nasal spray for fever due to common cold
ChiCTR2500101527Phase 3Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nasopharyngitis and upper respiratory infection (URI) comparing Bupleurum nasal spray placebo with Bupleurum nasal spray (2 arms). Primary endpoint: Complete defervescence time. Started Apr 2025; status: completed.
02
Drugs
bupleurum
03
Conditions
nasopharyngitisupper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2500101527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101527.